When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
PRVB - Provention Bio May Offer New Hope For People With Type 1 Diabetes With Latest Clinical Data
Provention Bio Inc.
Provention Bio (PRVB) announced positive results in a study known as "At Risk" to delay patients from gaining Type 1 diabetes (T1D). Such substantial results were presented at the Scientific Sessions of the 79th Annual American Diabetes Association ((ADA)) meeting. The bottom line is that treatment with PRV-031 (teplizumab) was able to have a significant impact on delaying the onset of Type 1 diabetes for patients. The biotech has made an impact on prevention of onset to T1D and is also currently exploring another aspect. This involves a phase 3 study for